About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Personalized HIV and STI Testing Tool | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT03109899

Personalized HIV and STI Testing Tool

The PHASTT Study is focused on understanding of facilitators and barriers to mHealth use among young Black men who have sex with men (MSM), and testing a novel mobile app to increase HIV/STI testing a...

Lead sponsor: Public Health Foundation Enterprises, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Kenneth Coleman, MA

CONTACT

628-217-7443 kenneth.coleman@sfdph.org

Hyman Scott, MD, MPH

CONTACT

628-217-7483 hyman.scott@sfdph.org

Sponsors

Lead Sponsor

Public Health Foundation Enterprises, Inc.

Collaborators

National Institute of Mental Health (NIMH)
San Francisco Department of Public Health
University of California, San Francisco

The Sex Pro mobile application (app) being tested facilitates home HIV-testing, home sexually transmitted infection (STI) test self-collection, and pre-exposure prophylaxis (PrEP) uptake. The app integrates a personalized HIV risk assessment with home HIV and STI testing options for young, Black MSM.

Age

18 - 29 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Self-identify as Black.
•Self-report being HIV negative.
•Report anal sex with at two or more male sex partners in the prior 12 months.
•Own an iOS or Android mobile phone.
•Willing and able to give written informed consent to participate in all activities outlined by the protocol.

Exclusion Criteria

•Inadequate contact information for follow-up
•In a mutually monogamous sexual relationship for the past 12 months
•Currently taking PrEP
•Does not have reliable access to the internet
•Does not live, work or play in the San Francisco Bay Area
•Currently enrolled in another HIV intervention study
•Prior enrollment in an HIV vaccine trial with receipt of experimental vaccine product
•Any medical, psychiatric, or social condition, or occupational, or other responsibility that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Related studies

Thinking and Memory Problems in People With HIV

NCT01875588 · HIV Positive

RECRUITINGPhase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation

Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

NCT06857071 · Undiagnosed HIV Infection, Populations That Are Reluctant to Test for HIV, and more

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more

Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand

NCT07509853 · HIV Prevention, Substance Use, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 20, 2020Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment80

Start dateSep 2019

Last updatedFeb 20, 2020

Condition

Risk Reduction HIV Sexually Transmitted Infections (Not HIV or Hepatitis)

Locations shown

Bridge HIV, San Francisco Department of Public Health

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2020Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions